# Neutralizing Power of Serum Antibodies - 2

> **NCT07085611** · NA · RECRUITING · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 30 (estimated)

## Conditions studied

- COVID-19
- SARS-CoV-2 Viraemia
- Monkey Pox
- Vaccination
- Serum
- Mucosal Immunity

## Interventions

- **OTHER:** Sample collection (blood and optional nasal swab)

## Key facts

- **NCT ID:** NCT07085611
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-22
- **Primary completion:** 2030-08-22
- **Final completion:** 2035-07-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07085611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07085611, "Neutralizing Power of Serum Antibodies - 2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07085611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*